InBody Co.,Ltd (KOSDAQ:041830)
 28,650
 +1,700 (6.31%)
  Oct 31, 2025, 3:30 PM KST
InBody Co.,Ltd Market Cap
InBody Co.,Ltd has a market cap or net worth of 328.58 billion as of October 30, 2025. Its market cap has increased by 1.91% in one year.
Market Cap 
 328.58B
Enterprise Value 
 243.78B
Revenue 
 217.55B
Ranking 
 n/a
PE Ratio 
 11.18
Stock Price 
28,650.00
Market Cap Chart
Since November 3, 2004, InBody Co.,Ltd's market cap has increased from 10.60B to 328.58B, an increase of 2,999.24%. That is a compound annual growth rate of 17.76%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 328.58B | 10.44% | 
| Dec 30, 2024 | 297.52B | -9.91% | 
| Dec 28, 2023 | 330.23B | 25.50% | 
| Dec 29, 2022 | 263.14B | -12.74% | 
| Dec 30, 2021 | 301.57B | 33.43% | 
| Dec 30, 2020 | 226.02B | -28.16% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 86.90T | 
| Celltrion | 38.62T | 
| ALTEOGEN | 25.24T | 
| SK Biopharmaceuticals | 8.88T | 
| Yuhan | 8.68T | 
| HLB Co., Ltd. | 6.38T | 
| Peptron | 6.13T | 
| PharmaResearch | 5.65T |